InformationTDZD-8 (NP 01139) is a non-ATP competitiveGSK-3βinhibitor withIC50of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.In vitroTDZD-8 acts as a noncompetitive inhibitor of ATP or GS-1 binding. TDZD-8 shows no inhibition of PKA, PKC, Cdk-1/cyclin B or CK-II in kinase assays. TDZD-8 specifically induces cell death of primary leukemia specimens. TDZD-8 ablates leukemia progenitor and stem cells. TDZD-8 treatment induces oxidative stress. TDZD-8 induces cell death with extremely rapid cell death kinetics showing loss of membrane integrity. TDZD-8 inhibits PKC and FLT3 in primary AML specimens.In vivoCell Datacell lines:Concentrations:Incubation Time:Powder Purity:≥99%.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C10H10N2O2S
Molecular Weight: 222.26
- UPC:
- 12141750
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- T409003-1ml
- CAS:
- 327036-89-5
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





